Brind.
  1. Medicare spending cuts are affecting diabetes device companies like Insulet and Dexcom.
  2. CMS proposed payment reductions impacting diabetes care.

Dexcom submitted positive CONNECT trial results to CMS.

1 report, 1 independent Updated Jul 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Dexcom submitted positive CONNECT trial results to CMS.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped